{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"0.116","rs_stock_flag":false,"fiscal_year_end":"31 Mar 2025","hist_closedate":"25 Sep 2025","replication_method":null,"amt_os":"1,850,425,060","primaryexch":"HKEX","ric":"0928.HK","product_subtype":null,"db_updatetime":"26 Sep 2025 18:38","mkt_cap_u":"M","am_u":"K","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BM8GF19","am":"246.62","iv":"","ew_strike":"","as":"0.110","geographic_focus":null,"incorpin":"Cayman Islands","etp_baseCur":null,"ew_amt_os":"","bd":"0.106","registrar":"Tricor Tengis Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"20,000","update_time":"2025-09-26 10:38:37.0","lo52":"0.024","shares_issued_date":"31 Aug 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"Yan Ming and Leng Yueyingtan","underlying_ric":"0928.HK","hi52":"0.150","issuer_name":"King International Investment Ltd.","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"26 Sep 2025 15:58","aum_date":"","lo":"0.106","mkt_cap":"203.54","f_aum_hkd":null,"ew_sub_per_to":"","ls":"0.110","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"0.000","aum":"","issued_shares_class_B":null,"vo":"2.24","secondary_listing_flag":false,"listing_date":"29 Apr 2002","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"King International Investment Ltd.","nm_s":"KING INTL INV","sym":"928","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.001","strike_price":"","summary":"King International Investment Ltd is an investment holding company principally engaged in health products and services. The Company operates its business through two segments. The Healthcare Products and Services Business segment is principally engaged in the provision of genetic testing, health data analysis services and health product trading services. The Sales of Liquor Business segment is principally engaged in the sale of Maotai-flavor liquor and other liquors.","op":"0.106","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Biotechnology","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"1101, 11th Floor<br/>Gloucester Tower, The Landmark<br/>15 Queen's Road Central<br/>Hong Kong","pc":"0.00","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"HKD","hdr":false,"launch_date":"","hc":"0.110","isin":"KYG5924H1231","moneyness":""}},"qid":"1758890831990"}
